Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
Bernadette A. M. Heemskerk-Gerritsen
Agnes Jager
Linetta B. Koppert
A. Inge-Marie Obdeijn
Margriet Collée
Hanne E. J. Meijers-Heijboer
Denise J. Jenner
Hester S. A. Oldenburg
Klaartje van Engelen
Jakob de Vries
Christi J. van Asperen
Peter Devilee
Marinus J. Blok
C. Marleen Kets
Margreet G. E. M. Ausems
Caroline Seynaeve
Matti A. Rookus
Maartje J. Hooning
机构：
[1] Erasmus MC Cancer Institute,Department of Medical Oncology
[2] Erasmus MC Cancer Institute,Department of Surgery
[3] Erasmus MC Cancer Institute,Department of Radiology
[4] Erasmus MC Cancer Institute,Department of Clinical Genetics
[5] Academic Medical Center,Department of Clinical Genetics
[6] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Epidemiology
[7] Netherlands Cancer Institute,Department of Surgery
[8] VU University Medical Center,Department of Clinical Genetics
[9] University Medical Center Groningen,Department of Surgery
[10] Leiden University Medical Center,Department of Clinical Genetics
[11] Leiden University Medical Center,Department of Human Genetics
[12] Maastricht University Medical Center,Department of Clinical Genetics
[13] Radboud University Medical Center,Department of Human Genetics
[14] University Medical Center Utrecht,Department of Medical Genetics
来源：
Breast Cancer Research and Treatment | 2019年 / 177卷
关键词：
Bilateral risk-reducing mastectomy; Prevention; Surveillance; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：723 / 733
页数：10
相关论文
共 50 条
  • [21] Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
    Metcalfe, Kelly
    Huzarski, Tomasz
    Gronwald, Jacek
    Kotsopoulos, Joanne
    Kim, Raymond
    Moller, Pal
    Pal, Tuya
    Aeilts, Amber
    Eisen, Andrea
    Karlan, Beth
    Bordeleau, Louise
    Tung, Nadine
    Olopade, Olufunmilayo
    Zakalik, Dana
    Singer, Christian F.
    Foulkes, William
    Couch, Fergus
    Neuhausen, Susan L.
    Eng, Charis
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    BRITISH JOURNAL OF CANCER, 2023, 130 (2) : 269 - 274
  • [22] Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
    Conduit, Ciara
    Milne, Roger L.
    Friedlander, Michael L.
    Phillips, Kelly-Anne
    CANCER PREVENTION RESEARCH, 2021, 14 (11) : 983 - 993
  • [23] Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
    Mavaddat, Nasim
    Antoniou, Antonis C.
    Mooij, Thea M.
    Hooning, Maartje J.
    Heemskerk-Gerritsen, Bernadette A.
    Nogues, Catherine
    Laborde, Lilian
    Breysse, Emmanuel
    Stoppa-Lyonnet, Dominique
    Gauthier-Villars, Marion
    Buecher, Bruno
    Caron, Olivier
    Fourme-Mouret, Emmanuelle
    Fricker, Jean-Pierre
    Lasset, Christine
    Bonadona, Valerie
    Berthet, Pascaline
    Faivre, Laurence
    Luporsi, Elisabeth
    Mari, Veronique
    Gladieff, Laurence
    Gesta, Paul
    Sobol, Hagay
    Eisinger, Francois
    Nogues, Catherine
    Longy, Michel
    Dugast, Catherine
    Colas, Chrystelle
    Coupier, Isabelle
    Pujol, Pascal
    Corsini, Carole
    Lortholary, Alain
    Vennin, Philippe
    Adenis, Claude
    Nguyen, Tan Dat
    Delnatte, Capucine
    Tinat, Julie
    Tennevet, Isabelle
    Limacher, Jean-Marc
    Maugard, Christine
    Bignon, Yves-Jean
    Demange, Liliane
    Penet, Clotilde
    Dreyfus, Helene
    Cohen-Haguenauer, Odile
    Venat-Bouvet, Laurence
    Leroux, Dominique
    Zattara-Cannoni, Helene
    Fert-Ferrer, Sandra
    Bera, Odile
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [24] Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral
    Ingham, Sarah L.
    Sperrin, Matthew
    Baildam, Andrew
    Ross, Gary L.
    Clayton, Richard
    Lalloo, Fiona
    Buchan, Iain
    Howell, Anthony
    Evans, D. Gareth R.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 611 - 618
  • [25] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74
  • [26] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [27] Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral
    Sarah L. Ingham
    Matthew Sperrin
    Andrew Baildam
    Gary L. Ross
    Richard Clayton
    Fiona Lalloo
    Iain Buchan
    Anthony Howell
    D. Gareth R. Evans
    Breast Cancer Research and Treatment, 2013, 142 : 611 - 618
  • [28] The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
    J Iqbal
    A Ragone
    J Lubinski
    H T Lynch
    P Moller
    P Ghadirian
    W D Foulkes
    S Armel
    A Eisen
    S L Neuhausen
    L Senter
    C F Singer
    P Ainsworth
    C Kim-Sing
    N Tung
    E Friedman
    M Llacuachaqui
    S Ping
    S A Narod
    British Journal of Cancer, 2012, 107 : 2005 - 2009
  • [29] The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
    Iqbal, J.
    Ragone, A.
    Lubinski, J.
    Lynch, H. T.
    Moller, P.
    Ghadirian, P.
    Foulkes, W. D.
    Armel, S.
    Eisen, A.
    Neuhausen, S. L.
    Senter, L.
    Singer, C. F.
    Ainsworth, P.
    Kim-Sing, C.
    Tung, N.
    Friedman, E.
    Llacuachaqui, M.
    Ping, S.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 2005 - 2009
  • [30] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
12345